<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00324402</url>
  </required_header>
  <id_info>
    <org_study_id>2005008</org_study_id>
    <nct_id>NCT00324402</nct_id>
  </id_info>
  <brief_title>Plasma Brain Natriuretic Peptide Levels in Pregnancy</brief_title>
  <official_title>Plasma Brain Natriuretic Peptide Levels in Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oklahoma State University Center for Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oklahoma State University Center for Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the maternal blood concentrations of brain natriuretic peptide (BNP) during the
      second and third trimesters of a normal pregnancy. We will attempt to define a normal range
      for pregnancy and any outliers that may serve as markers for abnormal cardiovascular
      physiology.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The brain natriuretic peptide (BNP) is a useful marker for volume overload, increased filling
      pressures and stretching of the myocardium. The current literature contains limited and
      unreliable information regarding normal BNP values in pregnancy. After baseline
      echocardiogram to detect individuals with asymptomatic structural defects, the participants
      will submit to 3 blood draws during the second and third trimester and at delivery to
      determine normal pregnancy values.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">June 2008</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Cardiomyopathy</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Healthy pregnant women, 18-40</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy pregnant women, 18-40
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women age 18 to 40

          -  second trimester of pregnancy

        Exclusion Criteria:

          -  known cardiac or valvular disease,

          -  atrial fibrillation or other arrhythmia,

          -  pulmonary hypertension,

          -  chronic hypertension,

          -  hypertensive disorders of pregnancy,

          -  morbid obesity (BMI &gt; 40 kg/meter squared)

          -  history of sleep apnea

          -  multiple gestation

          -  known renal dysfunction

          -  medications known to affect cardiac function

          -  current or past abnormal echocardiogram
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kimberly A Sorensen, DO</last_name>
    <role>Study Chair</role>
    <affiliation>Oklahoma State University Center for Health Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John M Beal, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oklahoma State University Center for Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oklahoma State University Center for Health Sciences</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74127</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2006</study_first_submitted>
  <study_first_submitted_qc>May 10, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2006</study_first_posted>
  <last_update_submitted>July 8, 2008</last_update_submitted>
  <last_update_submitted_qc>July 8, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 9, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr. J. Martin Beal, assistant professor of Ob/Gyn</name_title>
    <organization>Oklahoma State University Center for Health Sciences</organization>
  </responsible_party>
  <keyword>brain natriuretic peptide</keyword>
  <keyword>pregnancy</keyword>
  <keyword>biomarker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Natriuretic Peptide, Brain</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

